Singular Genomics Systems, Inc.·4

Nov 13, 4:39 PM ET

Ghai Jyotsna 4

4 · Singular Genomics Systems, Inc. · Filed Nov 13, 2024

Insider Transaction Report

Form 4
Period: 2024-11-09
Ghai Jyotsna
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-11-09+2502,516 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-11-092503,250 total
    Common Stock (250 underlying)
Footnotes (3)
  • [F1]Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
  • [F3]The RSUs vest in 16 equal quarterly installments over four years measured from February 9, 2024.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4